These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38395514)

  • 1. Blockade of vasoactive intestinal peptide receptor 2 (VIPR2) signaling suppresses cyclin D1-dependent cell-cycle progression in MCF-7 cells.
    Asano S; Ono A; Baba K; Uehara T; Sakamoto K; Hayata-Takano A; Nakazawa T; Yanamoto S; Tanimoto K; Hashimoto H; Ago Y
    J Pharmacol Sci; 2024 Mar; 154(3):139-147. PubMed ID: 38395514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoactive intestinal peptide receptor 2 signaling promotes breast cancer cell proliferation by enhancing the ERK pathway.
    Asano S; Ono A; Sakamoto K; Hayata-Takano A; Nakazawa T; Tanimoto K; Hashimoto H; Ago Y
    Peptides; 2023 Mar; 161():170940. PubMed ID: 36603770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of PRIP, a phosphatidylinositol 4,5-bisphosphate binding protein, attenuates PI3K/AKT signaling and suppresses tumor growth in a xenograft mouse model.
    Maetani Y; Asano S; Mizokami A; Yamawaki Y; Sano T; Hirata M; Irifune M; Kanematsu T
    Biochem Biophys Res Commun; 2021 May; 552():106-113. PubMed ID: 33743346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Src regulates cell cycle proteins expression through protein kinase B/glycogen synthase kinase 3 beta and extracellular signal-regulated kinases 1/2 pathways in MCF-7 cells.
    Liu X; Du L; Feng R
    Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):586-92. PubMed ID: 23615537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZSTK474, a specific class I phosphatidylinositol 3-kinase inhibitor, induces G1 arrest and autophagy in human breast cancer MCF-7 cells.
    Wang Y; Liu J; Qiu Y; Jin M; Chen X; Fan G; Wang R; Kong D
    Oncotarget; 2016 Apr; 7(15):19897-909. PubMed ID: 26918351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II-induced transcriptional activation of the cyclin D1 gene is mediated by Egr-1 in CHO-AT(1A) cells.
    Guillemot L; Levy A; Raymondjean M; Rothhut B
    J Biol Chem; 2001 Oct; 276(42):39394-403. PubMed ID: 11502738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitogenic activity of estrogens in human breast cancer cells does not rely on direct induction of mitogen-activated protein kinase/extracellularly regulated kinase or phosphatidylinositol 3-kinase.
    Gaben AM; Saucier C; Bedin M; Redeuilh G; Mester J
    Mol Endocrinol; 2004 Nov; 18(11):2700-13. PubMed ID: 15297603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
    Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
    Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways.
    Chen C; Chang YC; Lan MS; Breslin M
    Int J Oncol; 2013 Mar; 42(3):1113-9. PubMed ID: 23354006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells.
    Gao N; Flynn DC; Zhang Z; Zhong XS; Walker V; Liu KJ; Shi X; Jiang BH
    Am J Physiol Cell Physiol; 2004 Aug; 287(2):C281-91. PubMed ID: 15028555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AlphaFold version 2.0 elucidates the binding mechanism between VIPR2 and KS-133, and reveals an S-S bond (Cys
    Sakamoto K; Asano S; Ago Y; Hirokawa T
    Biochem Biophys Res Commun; 2022 Dec; 636(Pt 1):10-16. PubMed ID: 36332470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SHP2 promotes proliferation of breast cancer cells through regulating Cyclin D1 stability
    Yuan Y; Fan Y; Gao Z; Sun X; Zhang H; Wang Z; Cui Y; Song W; Wang Z; Zhang F; Niu R
    Cancer Biol Med; 2020 Aug; 17(3):707-725. PubMed ID: 32944401
    [No Abstract]   [Full Text] [Related]  

  • 13. PYK2 signaling is required for PDGF-dependent vascular smooth muscle cell proliferation.
    Perez J; Torres RA; Rocic P; Cismowski MJ; Weber DS; Darley-Usmar VM; Lucchesi PA
    Am J Physiol Cell Physiol; 2011 Jul; 301(1):C242-51. PubMed ID: 21451101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN sensitizes MDA-MB-468 cells to inhibition of MEK/Erk signaling for the blockade of cell proliferation.
    Jang K; Kim M; Seo HS; Shin I
    Oncol Rep; 2010 Sep; 24(3):787-93. PubMed ID: 20664988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling pathways activated by PACAP in MCF-7 breast cancer cells.
    Zibara K; Zeidan A; Mallah K; Kassem N; Awad A; Mazurier F; Badran B; El-Zein N
    Cell Signal; 2018 Oct; 50():37-47. PubMed ID: 29935235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulates proliferation of HAPI microglia by affecting the Akt/GSK-3β/cyclin D1 signaling pathway.
    Xu G; Li Y; Yoshimoto K; Wu Q; Chen G; Iwata T; Mizusawa N; Wan C; Nie X
    Toxicol Lett; 2014 Jan; 224(3):362-70. PubMed ID: 24231000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
    Datta NS; Chen C; Berry JE; McCauley LK
    J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cross-talk between PI3K/Akt and MEK/ERK pathways regulates human hepatocellular carcinoma cell cycle progression under endoplasmic reticulum stress].
    Yan DM; Dai RY; Duan CY; Chen SK; Liu YP; Chen CN; Li H
    Zhonghua Gan Zang Bing Za Zhi; 2010 Dec; 18(12):909-14. PubMed ID: 21205476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway.
    Zhao Y; Chen X; Cai L; Yang Y; Sui G; Fu S
    J Cell Physiol; 2010 Oct; 225(1):168-73. PubMed ID: 20458733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukotriene B
    Li S; Zhai C; Shi W; Feng W; Xie X; Pan Y; Wang J; Yan X; Chai L; Wang Q; Zhang Q; Liu P; Li M
    Eur J Pharmacol; 2020 Jan; 867():172823. PubMed ID: 31770525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.